Study finds reduced risk of cataracts associated with obesity surgery
New experimental drug cagrilintide (AM833), when combined with emaglutide, shows potential for treatment of obesity
13 May 2021Vaccinating children against SARS-CoV-2
13 May 2021Study finds reduced risk of cataracts associated with obesity surgery
New research presented at this year’s European Congress on Obesity (held online 10-13 May) has found a reduced risk of eye cataracts occurring in patients who have lost weight through obesity (bariatric) surgery. The study is by Dr. Theresa Burkard, ETH Zurich, Switzerland, and colleagues from Sweden and Switzerland.
